MSMB Capital Offers to Acquire Amag Pharmaceuticals (AMAG) for $18/Share

Article Stock Quotes (1) Comments (0)

MSMB Capital Management made a proposal to the Board of Directors of Amag Pharmaceuticals Inc. (NASDAQ: AMAG) to acquire all of the outstanding shares of common stock of Amag for $18 per share in cash or an aggregate of $378 million.

This proposal represents an approximate 25% premium above the closing price of Amag stock of $14.39 on August 2, 2011.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Bausch & Lomb near deal to sell to Valeant Pharmaceuticals (VRX) - WSJ
• Iconix Brand Group (ICON) Buys Remaining Interest in IP Holdings
• Sonic Automotive (SAH) Buys Murray BMW of Denver and Mercedes-Benz of Denve

Create E-mail Alert Related Categories

Hot M&A, Mergers and Acquisitions, Private Equity

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?